Publications by authors named "Hanxi Zhao"

Claim this Profile
R
Real-time magnetic resonance imaging guided accelerator in stereotactic body radiation therapy for non-small cell lung cancer.
Qiang Qiao, Wanqi Zhu, Changna Tian, Xihua Shi, Peng Xie, Hanxi Zhao

J Thorac Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling.
Shunkang Wu, Yuelin Deng, Haobo Sun, Xuewen Liu, Shuo Zhou, Hanxi Zhao, Xinying Zhao

Signal Transduct Target Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusarium graminearum rapid alkalinization factor peptide negatively regulates plant immunity and cell growth via the FERONIA receptor kinase.
Yujie Wang, Xin Liu, Bingqin Yuan, Xue Chen, Hanxi Zhao

Plant Biotechnol J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer.
Xiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, Guangjian Yang, Xianguang Zhao, Kaikai Zhao, Hong Zhao, Hanxi Zhao

BMC Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporally-coordinated bivalent histone modifications of BCG1 enable fungal invasion and immune evasion.
Xiaozhen Zhao, Yiming Wang, Bingqin Yuan, Hanxi Zhao, Yujie Wang

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial.
Jingjing Xie, Li Jia, Peng Xie, Xiaoyan Yin, Wanqi Zhu, Hong Zhao, Hanxi Zhao

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial.
Hanxi Zhao, Wanqi Zhu, Xianguang Zhao, Xiaolin Li, Zhengbo Zhou

JAMA Dermatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Mechanism of Stem Cell Aging.
Liangyu Mi, Junping Hu, Na Li, Jinfang Gao, Rongxiu Huo, Hanxi Zhao

Stem Cell Rev Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease.
Rongxiu Huo, Qianyu Guo, Junping Hu, Na Li, Rui Gao, Zhaoliang Zhang, Hanxi Zhao

Drug Des Devel Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of Chinese patients with KRAS-mutant non-small cell lung cancer after chemotherapy.
Yawen Zheng, Qinghua Lai, Hanxi Zhao, Xiaolin Li, Xiaorong Sun

Cancer Commun (Lond)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study.
Wanqi Zhu, Yalan Zhao, Shuyu Zhang, Xiaolin Li, Ligang Xing, Hanxi Zhao

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.
Wanqi Zhu, Hui Mei, Li Jia, Hanxi Zhao, Xiaolin Li, Xianguang Zhao

Invest New Drugs· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between the changes of skin temperature and radiation skin injury.
Wanqi Zhu, Li Jia, Guanxuan Chen, Xiaolin Li, Xiangjiao Meng, Hanxi Zhao

Int J Hyperthermia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer.
Xiaoling Li, Ligang Xing, Yujun Zhang, Peng Xie, Wanqi Zhu, Hanxi Zhao

J Med Food· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy.
Hanxi Zhao, Li Jia, Guanxuan Chen, Xiaolin Li, Xiangjiao Meng, Xianguang Zhao

Radiother Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF.
Xiangjiao Meng, Huijuan Li, Lingling Kong, Xianguang Zhao, Zhaoqin Huang, Hanxi Zhao

J Magn Reson Imaging· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Wanqi Zhu, Li Jia, Guanxuan Chen, Hanxi Zhao, Xiaorong Sun, Xianguang Zhao

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Hanxi Zhao, Wanqi Zhu, Li Jia, Xiaorong Sun, Guanxuan Chen, Xianguang Zhao

Br J Radiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer.
Xiangjiao Meng, Zhaoqin Huang, Jian Di, Dianbin Mu, Yawei Wang, Xianguang Zhao, Hanxi Zhao

Medicine (Baltimore)· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer.
Hanxi Zhao, Peng Xie, Xiaolin Li, Wanqi Zhu, Xindong Sun

Radiother Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.
Hanxi Zhao, Wanqi Zhu, Peng Xie, Huiqin Li, Xiqin Zhang

Radiother Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.
Peng Xie, Minghuan Li, Hanxi Zhao, Xindong Sun, Zheng Fu

J Cancer Res Clin Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Peng Xie, Jin-Bo Yue, Han-Xi Zhao, Xin-Dong Sun, Li Kong

J Cancer Res Clin Oncol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[From the local tumor recurrence status to discuss the target delineation in radiotherapy for non-small cell lung cancer].
Xin-Dong Sun, Jin-Bo Yue, Han-Xi Zhao

Zhonghua Zhong Liu Za Zhi· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis